Medical information Clinical review pending

Genetic Testing

MTHFR Gene Mutation Qualitative PCR Test

The MTHFR Gene Mutation Qualitative PCR Test identifies genetic variations in the MTHFR gene, which can influence the risk of thromboembolic disorders like blood clots. This test helps assess genetic predisposition for personalized healthcare.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: 3 mL (2 mL minimum) of whole blood collected in a Lavender Top (EDTA) tube.
Results: Confirm with the laboratory before booking.
Preparation: No specific patient preparation is required for this blood test. Confirm with the laboratory before booking.

Test priceKSh 9,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the MTHFR Gene Mutation Qualitative PCR Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Personal or family history of thromboembolic disorders (e.g., DVT, PE)
✓Unexplained blood clots
✓Elevated homocysteine levels
✓Planning for pregnancy
✓Recurrent pregnancy loss
✓Individuals considering folate supplementation
✓Assessment of risk for cardiovascular events

In plain language

What this test helps you understand

This test helps identify genetic variations in the MTHFR gene associated with an increased risk of thromboembolic disorders. It aids in assessing individual predisposition and informing personalized healthcare decisions, particularly regarding risk management and potential preventative measures.

The MTHFR Gene Mutation Qualitative PCR Test is a diagnostic tool used to identify specific mutations in the MTHFR gene. This gene is important for processing folate and regulating homocysteine levels in the body. Certain variations in this gene can potentially increase an individual's risk for developing thromboembolic disorders, such as deep vein thrombosis (DVT) and pulmonary embolism (PE). Understanding these genetic factors is crucial for personalized healthcare management and risk assessment. This test detects the presence or absence of specific MTHFR gene mutations. Results can help healthcare providers understand potential risks and guide appropriate medical advice and management strategies. It is particularly relevant for individuals with a personal or family history of blood clots, unexplained clotting events, or elevated homocysteine levels. It may also be considered during pregnancy planning.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationNo specific patient preparation is required for this blood test. Confirm with the laboratory before booking.

Sample3 mL (2 mL minimum) of whole blood collected in a Lavender Top (EDTA) tube.

MethodologyQualitative Polymerase Chain Reaction (PCR).

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test detects specific MTHFR gene mutations but does not guarantee the development of thromboembolic disorders. Other genetic and environmental factors also play a role. Results should be interpreted by a qualified healthcare professional. This test does not identify all possible MTHFR mutations.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

The MTHFR gene provides instructions for making an enzyme that processes folate (vitamin B9) and helps regulate homocysteine levels in the body. These processes are important for many bodily functions.

Certain variations in the MTHFR gene can affect how well the enzyme works, potentially increasing the risk for conditions like blood clots (thromboembolic disorders). This test helps identify these variations.

Individuals with a history of blood clots, a family history of clotting disorders, unexplained clotting events, elevated homocysteine levels, or those planning pregnancy may benefit from this test.

A positive result indicates the presence of specific MTHFR gene mutations. Your doctor will interpret this result along with your medical history to assess your risk and discuss appropriate management.

The test requires a blood sample, typically collected in a lavender-top tube. DNA Labs offers convenient sample collection at our branches or through a home collection service.

Turnaround time varies. Please confirm the current estimated turnaround time with the laboratory before booking your test.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp